Brainomix (now part of Oxford Biomedica) provides AI-powered stroke imaging analysis,with applications in cerebrovascular clinical trial endpoints and patient selection.
12Studies managed
Vendor description
Brainomix (now part of Oxford Biomedica) provides AI-powered stroke imaging analysis,with applications in cerebrovascular clinical trial endpoints and patient selection.
Stroke and neurovascular trials requiring AI imaging assessment
- Stroke imaging AI
- University of Oxford spinout
- CE-marked
- Stroke/neurology focus
- Not trial ops
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United Kingdom |
|---|---|
| Geography | Global |
| Study phases | Phase II, Phase III, Phase IV |
| Trial scale | Small,Medium |
| Therapeutic areas | Neurology, Stroke |
Related vendors
Editorial ranking
See how Brainomix compares - best AI / Machine Learning vendors for clinical trials.